Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acetylcholine receptor
acetylcholine receptor antibody
adverse drug reaction
algorithm
alpha-fetoprotein
alveolar hypoventilation
amyloidosis
amyotrophic lateral sclerosis
anesthesia, general
anesthesia, local
anticholinesterase
antimetabolite
arthrogryposis multiplex
aspiration
autoimmune disease
azathioprine
bacterial infection
blood gases, arterial
body temperature
breast feeding
CAT scan
CAT scan, complication with
CAT scan, contrast enhanced
cesarean section
Charcot-Marie-Tooth
children
cholinergic crisis
cholinergic drug
clostridium defficile infection
comorbidities
complications
contrast agents, neurotoxicity of
cost
cost effectiveness
critical care unit
dermatomyositis
diaphragmatic paralysis
diplopia
drug induced neurologic disorders
efficacy
emergencies, neurologic
epidemiology of neurology
fatigue
fever
gammaglobulin therapy, intravenous
Guillain Barre syndrome
heat exposure
heat intolerance
heralding manifestation
HLA
hospital length of stay
hyperthermia
immunosuppressive agents
incidence
intubation
klippel feil syndrome
labor, complicated
lipoprotein receptor-related protein 4
magnesium sulfate
mestinon
monoclonal antibodies
mononeuropathy
mortality
motor neuron disease
multiple organ failure
muscle diseases, characteristics of
muscle weakness
muscle weakness, proximal
muscle, metabolic disorders of
muscular dystrophy
muscular dystrophy, Duchenne
muscular dystrophy, facioscapulohumeral
muscular dystrophy, limb-girdle
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, complications
myasthenia gravis, diagnosis
myasthenia gravis, exacerbation
myasthenia gravis, infantile and juvenile
myasthenia gravis, neonatal
myasthenia gravis, ocular
myasthenia gravis, precipitating factors
myasthenia gravis, presenting manifestations
myasthenia gravis, prognosis of
myasthenia gravis, receptor site in
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, variants
myasthenic crisis
myocarditis
myopathy
myopathy, carcinomatous
myopathy, thyroid disease causing
myositis
myotonia dystrophica
neuritis, causes of
neurologic disease, diagnoses of
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuropathy
neuropathy, diabetic
old age, neurology of
ophthalmoplegia
plasmapheresis
pneumonia
poliomyelitis
polymyositis
polyneuropathy
porphyria
practice guidelines
precipitating factors
pregnancy, neurologic complications in
prognosis
ptosis
ptosis, bilateral
pulmonary function tests
quality of life
respirator
respiratory arrest
respiratory failure
respiratory tract infection
review article
risk factors
rituximab
sarcoidosis
septicemia
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
stillbirth
sudden death
thymectomy
thymic hyperplasia
thymoma
thyroiditis
torticollis
treatment of neurologic disorder
viral infection
vital capacity
weakness
weakness, fatiguable
weakness, generalized
Werdnig-Hoffman disease
Showing articles 100 to 150 of 322 << Previous Next >>

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006

Statin-Associated Myasthenia Gravis
Medicine 85:82-85, Purvin,V.,et al, 2006

A Diagnostic Approach to Multiple Simultaneous Intracerebral Hemorrhages
Neurocrit Care 4:267-271, Finelli,P.F., 2006

Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006

Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006

Lambert-Eaton Myasthenic Syndrome Associated With Thymitis
Neurol 64:168-169, Warren,N.M.,et al, 2005

Discontinuing Prophylactic Transfusions Used to Preven Stroke in Sickle Cell Disease
NEJM 353:2769-2778,2743, The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators, 2005

Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005

Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005

Apoplexy in Pituitary Macroadenoma: Eight Patients Presenting in 12 Months
Medicine 84:188-196, Imboden,E.,e tal, 2005

Upward Transtentorial Herniation, Hydrocephalus, and Cerebellar Edema in Hypertensive Encephalopathy
Neurologist 11:171-175, Adamson, C.D.,et al, 2005

Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004

Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004

Brainstem Involvement in Hypertensive Encephalopathy
Neurol 62:1417-1419, Cruz-Flores,S.,et al, 2004

Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

An Unconsious Girl with Sickle-Cell Disease
Lancet 361:136, van Mierlo,T.D.,et al, 2003

Pernicious Anemia with Neuropsychiatric Dysfunction in a Patient with Sickle Cell Anemia Treated with Folate Supplementation
NEJM 348:2204-2207, Dhar,M.,et al, 2003

Risk of Stroke in Children
Neurol 61:189-194, Fullerton,H.J.,et al, 2003

Brain Injury in Children with Sickle Cell Disease: Prevalence and Etiology
Ann Neurol 54:564-572,559, Steen,R.G.,et al, 2003

Paraneoplastic Syndromes Involving the Nervous System
NEJM 349:1543-1554, Darnell,R.B. &Posner,J.B., 2003

Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003

Sickle Cell Disease: The Neurological Complications
Ann Neurol 51:543-552, Prengler,M.,et al, 2002

Delayed Neuropathy and Myelopathy After Organophosphate Intoxication
NEJM 347:1119-1121, Chuang,C.,et al, 2002

Difference in Distribution of Muscle Weakness Between Myasthenia Gravis and the Lambert-Eaton Myasthenic Syndrome
JNNP 73:766-768, Wirtz,P.W.,et al, 2002

Seronegative Lambert-Eaton Myasthenic Syndrome
Neurol 59:1773-1775, Nakao,Y.K.,et al, 2002

Improved Cerebrovascular Patency Following Therapy in Patients with Sickle Cell Disease: Initial Results in 4 Patients Who Received HLA-Identical Hematopoietic Stem Cell Allografts
Ann Neurol 49:222-229, Steen,R.G.,et al, 2001

Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001

Brain Stem Compression by a Giant Vertebrobasilar Aneurysm Mimicking Seronegative Myasthenia
JNNP 71:125-126, Frisby,J.,et al, 2001

Clinicopath Conf,Systemic Sclerosis with Scleroderma Renal Crisis
NEJM 345:596-605, Case 26-2001, 2001

Clinicopath Conf, Non-Small-Cell Carcinoma of Lung, Metastatic to Hypothalamus, Pituitary Stalk and Pituitary Gland
NEJM 345:1483-1495, Case 35-2001, 2001

Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity
Arch Neurol 58:2017-2021, Pegelow,C.H.,et al, 2001

A Randomized Trial of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Neurol 54:603-607, Sanders,D.B.,et al, 2000

Unusual MR Findings of the Brain Stem in Arterial Hypertension
AJNR 21:391-394,243, deSeze,J.,et al, 2000

Neuro-Ophthalmologic Manifestations of a paraneoplastic Syndrome and Testicular Carcinoma
Neurol 52:864-867, Bennett,J.L.,et al, 1999

Thrombotic Thrombocytopenic Purpura:Brain CT and MRI Findings in 12 Patients
Neurol 52:1285-1288, Bakshi,R.,et al, 1999

Oculogyric Crisis as an Initial Manifestation of Wilson's Disease
Neurol 52:714-715, Lee,M.S.,et al, 1999

Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999

Paraneoplastic Syndromes
Arch Neurol 56:405-408, Dalmau,J.O.&Posner,J.B., 1999

Hypertensive Brainstem Encephalopathy:Three Cases Presenting with Severe Brainstem Edema
Neurol 53:652-654, Chang,G.Y.&Keane,J.R., 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999

Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998

Posterior Leukoencephalopathy Without Severe Hypertension,Utility of Diffusion-Weighted MRI
Neurol 51:1369-1376, Ay,H.,et al, 1998

Ion Channels and Neurological Disease:DNA Based Diagnosis is Now Possible,and Ion Channels May be Important in Common Paroxysmal Disorders
JNNP 65:427-431, Hanna,M.G.,et al, 1998

Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome
AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998

Acetylcholine Receptor Antibodies in the Lambert-Eaton Myasthenic Syndrome
Neurol 50:470-475, Katz,J.S.,et al, 1998

Neurology and the Blood:Haematological Abnormalities in Ischaemic Stroke
JNNP 64:150-159, Markus,H.S.&Hambley,H., 1998

Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998



Showing articles 100 to 150 of 322 << Previous Next >>